You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. Stocks
  2. Corcept Therapeutics Inc
  3. Swot
swot-logo

Corcept Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Corcept Therapeutics Inc has 18 Strengths, 6 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Price crossing above SMA20 today, and greater than SMA5

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Consistent Highest Return Stocks over Five Years - Nifty500

Expensive Rockets (DVM)

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Company with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Top Gainers

Volume Shockers

High Volume, High Gain

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Recent Results: Declining Operating Profit Margin and Net Profits (YoY)

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks